Get the Stockscreener App
25.79
1.98%
0.50
Enovis Corp stock is traded at $25.79, with a volume of 990.25K.
It is up +1.98% in the last 24 hours and up +13.06% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$25.29
Open:
$25.69
24h Volume:
990.25K
Relative Volume:
0.97
Market Cap:
$1.47B
Revenue:
$2.19B
Net Income/Loss:
$-829.17M
P/E Ratio:
-1.8098
EPS:
-14.25
Net Cash Flow:
$-3.95M
1W Performance:
+15.55%
1M Performance:
+13.06%
6M Performance:
-18.26%
1Y Performance:
-29.57%
1-Day Range:
$24.75
$26.01
1-Week Range:
$22.62
$26.41
52-Week Range:
$21.00
$40.70
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
25.79 | 1.45B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Why Enovis (ENOV) Is Up 10.5% After 2025 Losses And 2026 Growth Guidance - simplywall.st
Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation - Investing.com Nigeria
ENOV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enovis (NYSE:ENOV) Insider Purchases $25,500.00 in Stock - MarketBeat
Enovis (ENOV) HR chief reports 497 shares withheld for RSU taxes - Stock Titan
Enovis (ENOV) officer has 315 shares withheld to cover RSU taxes - Stock Titan
Enovis Corporation (ENOV): Investor Outlook On A Promising 75.8% Potential Upside - DirectorsTalk Interviews
Enovis Corp. Hits Day High with Strong 13.89% Intraday Surge - Markets Mojo
Enovis Outperforms Rennova Health in Financial Comparison - National Today
Enovis Reports Strong Q4 and Full-Year 2025 Results - National Today
Enovis Corporation $ENOV Shares Sold by Royce & Associates LP - MarketBeat
Vanguard Group Inc. Boosts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
A Look At Enovis (ENOV) Valuation After Earnings Beat And Higher 2026 Profit Guidance - simplywall.st
American Century Companies Inc. Sells 258,262 Shares of Enovis Corporation $ENOV - MarketBeat
AI Reliance Raises Operational, Regulatory, and Reputational Risks for Enovis Corporation - The Globe and Mail
Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth - simplywall.st
Enovis Corporation (NYSE:ENOV) Q4 2025 Earnings Call Transcript - Insider Monkey
Enovis Reports Strong 2025 Performance, Outlines 2026 Outlook - National Today
Enovis Balances Revenue Growth And New Devices With Goodwill Impairment - Yahoo Finance
Enovis Q4 Earnings Call Highlights - Yahoo Finance
Enovis Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:ENOV) 2026-02-27 - Seeking Alpha
Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating - marketscreener.com
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings - AOL.com
Needham Maintains Enovis Corp(ENOV.US) With Buy Rating, Raises Target Price to $52 - 富途牛牛
Enovis (NYSE:ENOV) Posts Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Oliver Engert Net Worth (2026) - GuruFocus
Enovis (ENOV) FY 2025 Loss Of US$9.07 EPS Tests Margin Turnaround Narrative - simplywall.st
Enovis Q4 2025 slides: margin expansion drives earnings beat By Investing.com - Investing.com Australia
Enovis tops profit expectations but revenue falls short - MSN
Needham raises Enovis stock price target to $52 on 2027 estimates - Investing.com Australia
Enovis Corp (ENOV) Q4 2025 Earnings Call Highlights: Strong Orga - GuruFocus
Enovis (ENOV) Receives Revised Price Target from BTIG | ENOV Sto - GuruFocus
Enovis reports Q4 adjusted EPS 95c, consensus 84c - TipRanks
Enovis (NYSE:ENOV) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Why Enovis (ENOV) Stock Is Trading Up Today - Yahoo Finance
Enovis Q4 2025 slides: margin expansion drives earnings beat - Investing.com
Enovis Q4 2025 Earnings Preview: Revenue Growth Forecast at 4.1%News and Statistics - IndexBox
Enovis (NYSE:ENOV) Stock Price Up 13.7% on Strong Earnings - MarketBeat
Earnings call transcript: Enovis beats Q4 2025 EPS forecast; stock rises - Investing.com
Earnings call transcript: Enovis beats Q4 2025 EPS forecast; stock rises By Investing.com - Investing.com South Africa
Enovis Q4 Adjusted Earnings Fall, Net Sales Rise; Issues Full-Year Adjusted Earnings, Net Sales Outlook - marketscreener.com
Enovis (NYSE:ENOV) Issues FY 2026 Earnings Guidance - MarketBeat
Enovis Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Enovis (ENOV) Q4 Earnings Beat Estimates - Yahoo Finance
Enovis Corporation Reports consolidated Unaudited Goodwill Impairment Charge for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Enovis posts 24% sales growth in mixed Q4 - MassDevice
Enovis Corporation Provides Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Earnings Flash (ENOV) Enovis Posts Q4 Adjusted EPS $0.95, vs. FactSet Est of $0.84 - marketscreener.com
ENOVIS ($ENOV) Releases Q4 2025 Earnings - Quiver Quantitative
Enovis earnings beat by $0.13, revenue fell short of estimates - Investing.com
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):